BioMarin's Vimizim should boost top-line growth and bring the firm to profitability.
By SA Editor Miriam Metzinger : Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday April 10. Bullish Calls: Service Corporation ( SCI ): "We have been faithful to Service Corporation in the funeral home industry. We will stick with that one. It is a very ...
By Don Dion : Applied Genetic Technologies Corp ( AGTC ), a clinical-stage biotechnology firm, developing treatments for severe inherited diseases of the eye, plans to raise $50.0 million in its upcoming IPO. The Alachua, Florida-based firm will offer 3.6 million shares at an expected price range
By Don Dion : UniQure BV ( QURE ), a leading gene therapy biopharmaceutical firm, with principal offices in Amsterdam, plans to raise $64 million in its upcoming IPO. The firm will offer 4.6 million shares at an expected price range of $13-$15 per share. If the IPO can reach the midpoint of that ...
By Don Dion : The RARE IPO Deal Ultragenyx Pharmaceutical ( RARE ), a development-stage biopharm firm, focused on the development of treatments for rare and ultra-rare diseases, plans to raise $94 million in its upcoming IPO on Friday, January 31. The Novato, California-based firm will offer 4.8 ...
think there will be huge charges because of the lawsuits. It is the best performer of the large cap oils. This is the one to buy of the majors." BioMarin ( BMRN ), Biogen Idec ( BIIB ), Gilead ( GILD ): "I think BMRN can Complete Story »
reviewed it after it fell apart. The stock is a wild trader, but the business is secure. We are not backing away." BioMarin ( BMRN ), NPS Pharmaceuticals ( NPSP ): Cramer prefers these stocks to MannKind. Genuine Parts ( GPC ): "It is a very good, consistent
HVAC (heating, ventilation and air conditioning) is one of the strongest currents right now in the action." BioMarin ( BMRN ): "They did a financing, and that has knocked the stock down. I still like that stock." FedEx ( FDX ), UPS ( UPS
Gilead ( GILD ), Novartis ( NVS ), Johnson & Johnson ( JNJ ), Medivation ( MDVN ), Seattle Genetics ( SGEN ), BioMarin ( BMRN ) Amgen ( AMGN ) announced it is buying Onyx Pharmaceuticals ( ONXX ) at a 50% premium, and the deal is a win-win for both
By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday July 1. Noodles & Company ( NDLS ). Other stock mentioned: Chipotle Mexican Grill ( CMG ) Noodles & Company ( NDLS ) was a red hot IPO that might go higher on a new food trend. It